Back to the main directory
EarningsReview / Equity
- Sandvik - Growth mode by Danske Bank Equity Research
- Significant FX headwinds impacted Q4 results by BNP Paribas
- Results Flash - EBITDA & FCF beat, divi miss, guidance in-line by BNP Paribas
- FQ1 26 revenue first-take: return to msd growth at cc confirmed as strategy shift bears fruit by BNP Paribas
- Valbiotis - Point d’activité 2025 by MidCap Partners
- Compagnie Des Alpes - Sur la bonne pente by MidCap Partners
- INVEST SECURITIES - VALBIOTIS : Dynamique solide au T4, perspectives 2027 inchangées - ACHAT, OC 2,0€ vs 2,1€ by Invest Securities
- HBX Group - 1Q26 trading update in line, guidance unchanged; buy by JB Capital Markets
- Fermentalg SA - Greater caution on the 2026 guidance by MidCap Partners
- Eurobio Scientific - 2025 Revenue by MidCap Partners
- ASML HOLDING NV: RDOS. 4T’25 (ANÁLISIS BANCO SABADELL) by Sabadell
- An introduction to Eurofins by BNP Paribas
- A Fresh Look at General Mills’ Launch into Fresh Dog Food by BNP Paribas
- Is Siemens taking back share in China? by BNP Paribas
- Q4'25 results: EBIT 1% miss but new orders and 2026 guidance below cons. expectations by BNP Paribas
- Q4-25 results first take - 1% ahead of expectations, mixed guidance, good subscription sales by BNP Paribas
- HBX Group - Mixed short-term message but FY26 on track by JB Capital Markets
- Read-across from GEV’s Dec.-quarter backs our positive view by BNP Paribas
- SSAB - 2026 lining up to be a good year by Danske Bank Equity Research
- Strong ASML orders/outlook bodes well for Jenoptik by BNP Paribas
- Sales and margins drive strong Q4 beat; Q1 EPS guided ahead, although implied organic sales below by BNP Paribas
- Gearing up for the fast lane by BNP Paribas
- 4Q25 earnings a slight miss by BNP Paribas
- USD impact and US Supreme Court decision on tariffs by BNP Paribas
- Conference call feedback - focus on manufacturing capacity by BNP Paribas